Research location
Saint-Girons
France
Advertisement
Research activity in Saint-Girons
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Saint-Girons
9 linked trials · page 1 of 1Personalized Management of Psycho-behavioral Symptoms in Alzheimer's Disease: Impact on Health Resources UseNCT04820127 · 2021-10-14 · 1 site observation
COMPLETED
Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01007734 · 2009-10-01 · 1 site observation
COMPLETED
Evaluation of the Control Level of Asthmatic Patients With Seasonal Increase of Respiratory Symptoms (High and/or Low)NCT00882128 · 2009-05-01 · 1 site observation
COMPLETED
Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)NCT00861926 · 2009-03-20 · 1 site observation
COMPLETED
Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's DiseaseNCT00646269 · 2008-03-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
Cardiovascular Risk Assessment in Patients Treated With CaduetNCT00297973 · 2006-02-01 · 1 site observation
COMPLETED
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureNCT00230763 · 2005-09-01 · 1 site observation
COMPLETED
A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory ComplaintsNCT00276510 · 2002-02-01 · 2 site observations
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.